About Molecular Infusions
Molecular Infusions is a company based in Los Angeles (United States) founded in 2016 was acquired by Surterra Wellness in June 2019. Molecular Infusions operates in a competitive market with competitors including Sanity Group, ZYUS Life Sciences, Terraflos, Avicanna and Tetra Bio-Pharma, among others.
- Headquarter Los Angeles, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Surterra Wellness
(Jun 25, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Molecular Infusions
Detailed funding history for Molecular Infusions
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Molecular Infusions
Molecular Infusions has secured backing from 1 investor. Prominent investors backing the company include Surterra.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Medical cannabis is cultivated and processed for therapeutic products.
|
Locked | Locked | Locked |
Investor details for Molecular Infusions
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Molecular Infusions
Investment portfolio details for Molecular Infusions
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Molecular Infusions
Detailed financials for Molecular Infusions
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Molecular Infusions Comparisons
Peer comparison for Molecular Infusions
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Molecular Infusions
Molecular Infusions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sanity Group, ZYUS Life Sciences, Terraflos, Avicanna and Tetra Bio-Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of cannabinoid-based pharmaceuticals and well-being products
|
|
| Locked | Locked | Locked |
Cannabis-derived therapeutics for multiple indications are developed.
|
|
| Locked | Locked | Locked |
Medical cannabis products are provided based on GMP processes.
|
|
| Locked | Locked | Locked |
Plant-derived cannabinoid products are developed for medical and consumer uses.
|
|
| Locked | Locked | Locked |
Natural medicinal plant-based elements are developed for treating multiple diseases.
|
|
| Locked | Locked | Locked |
Manufacturer of medicinal cannabis for therapeutic use
|
Detailed competitors of Molecular Infusions
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Molecular Infusions
Complete news archive for Molecular Infusions
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Molecular Infusions
Molecular Infusions was founded in 2016.
Molecular Infusions is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
Molecular Infusions was founded in 2016 in Los Angeles, United States. Operations are centered in the biotechnology sector, where cannabis-derived pharmaceuticals are developed to address various disorders. Cannabinoid-based formulations for oral, inhalation, and topical use are provided, along with delivery systems designed for therapeutic applications. Focus is placed on advancing treatments through these methods, with activities based in the U.S. healthcare innovation landscape.
Molecular Infusions's top competitors include Avicanna, ZYUS Life Sciences and Sanity Group.
Molecular Infusions has 1 investor. Key investors include Surterra.